ClinicalTrials.gg
RecruitingNCT06447077Updated Oct 1, 2026

Impact of a Predetermined Day 5 ET vs. a Predetermined Day 6 ET on Clinical Pregnancy Rate After ICSI Treatment

An observational study in Infertility and Reproductive Issues, sponsored by Infertility Treatment Center Dortmund. Recruiting at 1 site in Germany. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Infertility Treatment Center Dortmund · Observational

How we know

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 4 months later.
Updated Oct 1, 2026Sponsor changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,400
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Infertility with a site in Germany — 4 open to participants now, 4 under way, none of them phase 3. Infertility · Germany.

Planned enrollment
3rd of 10
2,400 · median 1,023
Started
2024
the only one that year
Observational
10 of 28
4 open now
Registered
27th of 28
by date
Lead sponsor
2 of 28
Infertility Treatment Center Dortmund

Among the 28 studies in Infertility with a site in Germany, this one is the 3rd largest by planned enrollment of the 10 observational ones that give a count, is the only one that started in 2024, is one of 10 observational ones, and was the 27th registered.

Infertility

2,090 studies on the registry are indexed under Infertility; 355 are open to participants now.

Browse Infertility studies →

Open to participants now

4 of the 28 studies in Infertility with a site in Germany are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 232 Infertility studies recruiting now, 43 (19%) set no upper age limit and 183 (79%) stop at 75 or younger; 27 take children under 18; 74 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Infertility with a site in Germany, or all of them as a file.
02

Study summary

The aim of this prospective multicenter study is to investigate the influence of a predetermined embryo transfer on day 6 compared to a predetermined embryo transfer on day 5. The study population consists of the control group (predetermined embryo transfer on day 5) and the study group (predetermined embryo transfer on day 6). The primary endpoint is the clinical pregnancy rate (detection of a gestational sac) per embryo transfer and the secondary endpoint is the abortion rate per clinical pregnancy. The data from the multicenter study are obtained at three test centers (Fertility Center Dortmund, Fertility Center Essen and Fertility Center Bad Münder).

Read the detailed description

Since a predetermined embryo transfer on day 5 cannot be performed in some centers on every day of the week (e.g. sunday), some IVF centers perform a predetermined embryo transfer on day 4 or day 6, respepectively. Data for a predetermined embryo transfer on day 4 versus a predetermined embryo transfer on day 5 showed no significant differences regarding clinical pregnancy rates. However, since a day 6 transfer might offer advantages in assessing the development stage, the prolonged culture and transfer on day 6 transfer might be a very promising option.

As of yet, there are no prospective studies in the current literature examining the equivalence of a predetermined embryo transfer on day 6 versus a predetermined embryo transfer on day 5.

The aim of this prospective multicenter study is to investigate the influence of a predetermined embryo transfer on day 6 compared to a predetermined embryo transfer on day 5. The study population consists of the control group (predetermined embryo transfer on day 5) and the study group (predetermined embryo transfer on day 6). The primary endpoint is the clinical pregnancy rate (detection of a gestational sac) per embryo transfer and the secondary endpoint is the abortion rate per clinical pregnancy. The data from the multicenter study are obtained at three test centers (Fertility Center Dortmund, Fertility Center Essen and Fertility Center Bad Münder).

03

Conditions studied

  • Infertility
  • Reproductive Issues

Browse trials for

Keywords

  • ICSI
  • Predetermined Day 6 Embryo Transfer
  • Predetermined Day 5 Embryo Transfer
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Female patients seeking ICSI treatment because of male subfertilit

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

The patients to be included should be ≥18 years old. There is no upper age limit. Only ICSI treatments with a single embryo transfer (SET) should be included. Only the first cycle per patient should be evaluated.

Exclusion criteria

Exclusion criteria:

none

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,400 participants (estimated)
Target follow-up
9 Months
Patient registry
Yes

Groups and cohorts

  • Predetermined embryo transfer on day 5

    The control group will include patients who have their oocyte pick-up on a monday (embryo transfer on saturday, day 5), wednesday (embryo transfer on monday, day 5), thursday (embryo transfer on tuesday, day 5), friday (embryo transfer on wednesday, day 5) and saturday (embryo transfer on thursday, day 5).

  • Predetermined embryo transfer on day 6

    The study group will include patients who have their oocyte pick-up on a tuesday (embryo transfer on monday, day 6).

06

What researchers measure

Primary outcomes

  1. Clinical pregnancy rate per embryo transfer

    Clinical pregnancy rate per embryo transfer (detection of a gestational sac)

    Time frame: 4 weeks after embryo transfer

Secondary outcomes

  1. Abortion rate per clinical pregnancy

    Abortion rate per clinical pregnancy (termination of an ongoing clinical pregnancy)

    Time frame: During entire ongoing pregnancy

07

Study locations

1 of 1 sites recruiting
  • Infertility treatment center Dortmund
    Dortmund, North Rhine-Westphalia 44135, Germany
    Recruiting
    • Stefan Dieterle · Contact00492315575450
    • Stefan Dieterle · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2024 (actual). Primary completion is estimated for Jan 2028, 43 months after the start.

Of 209 non-industry observational studies under Infertility, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 100. This study's planned 43 months is above that.

Counting every sponsor, half of 240 studies reached it within 39 months; a quarter within 16 and three quarters within 99.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2024
First posted
Jun 6, 2024
StartActual
Jun 26, 2024
Primary completionEst.
Jan 2028
CompletionEst.
Mar 2028
Last update
Oct 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sponsor
Collaborators added: MVZ Kinderwunschzentrum Godesberger Allee·Kinderwunsch Centrum München·MVZ Fertility Center Berlin
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    Sponsor Collaborators added: MVZ Kinderwunschzentrum Godesberger Allee·Kinderwunsch Centrum München·MVZ Fertility Center Berlin
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06447077
Lead sponsor
Infertility Treatment Center Dortmund
Collaborators
Fertility Center Dortmund, novum - Center for Reproductive Medicine Essen - Duisburg, Deutsche Klinik Bad Münder, MVZ Kinderwunschzentrum Godesberger Allee, Kinderwunsch Centrum München, MVZ Fertility Center Berlin
Responsible party
Prof. Dr. Stefan Dieterle (Principal Investigator, University of Witten/Herdecke) — Principal investigator
First posted
Jun 6, 2024
Start date
Jun 26, 2024
Primary completion
Jan 2028 (estimated)
Completion
Mar 2028 (estimated)
Last update
Oct 1, 2026

Study contacts

Stefan Dieterle, MD
Contact
dieterle@kinderwunschzentrum.org
00492315575450
Tom Trapphoff, DR
Contact
trapphoff@kinderwunschzentrum.org
00492315575450
Stefan Dieterle, MD
principal investigator · University of Witten/Herdecke

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion